Colistimethate SodiumThird Party Manufacturing in India

Colistimethate Sodium works by acting as a targeted biological detergent to break down the protective outer membranes of harmful bacteria.

As an inactive prodrug, it is converted in the body into the active compound colistin, which then binds directly to lipopolysaccharides and phospholipids in the outer membrane of Gram-negative bacteria. This binding displaces essential calcium and magnesium ions, disrupting the membrane's structural integrity. The resulting increase in membrane permeability causes the vital cell contents to leak out, leading to rapid bacterial cell death.

Unlike standard beta-lactam or macrolide antibiotics, Colistimethate Sodium targets the bacterial cell membrane rather than cell wall synthesis or ribosome function, making it highly effective against strains that have developed resistance to other drug classes. It is particularly valuable as a last-resort treatment for severe, multidrug-resistant systemic and pulmonary infections in hospitalized patients.

Therapeutic Uses

Colistimethate Sodium is prescribed for the treatment of:

• Multidrug-Resistant Infections: Used to treat severe infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae when other options fail.
• Ventilator-Associated Pneumonia: Indicated for hospital-acquired respiratory tract infections in critically ill patients.
• Chronic Pulmonary Infections: Administered via inhalation to manage pseudomonal lung infections in patients with cystic fibrosis.
• Complicated Urinary Tract Infections: Prescribed for deep-seated urinary tract infections resistant to standard antimicrobials.

Why Manufacturers Choose Colistimethate Sodium

Colistimethate Sodium is a highly specialized, high-value sterile injectable antibiotic. As multidrug-resistant 'superbugs' rise globally, this molecule has transitioned from a last-resort therapy to an essential clinical requirement in intensive care units worldwide. For third party manufacturers and PCD distributors, offering a reliable supply of Colistimethate Sodium injectables is key to securing institutional contracts and hospital supply networks. Indian WHO-GMP certified facilities are uniquely positioned to manufacture this sterile powder for injection at scale, ensuring strict adherence to environmental controls and purity standards required by international buyers.

This makes Colistimethate Sodium one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.